Is SMARCA4 p.Ser492= (c.1476C>T) pathogenic?

SMARCA4 p.Ser492= (c.1476C>T) is classified Likely benign in SMARCA4 (ClinVar, Multiple submitters, 5 submitters; last evaluated 2025-12-22). Ultra-rare (popmax 0.049%, eas); Associated with hereditary neoplastic syndrome.

What condition is associated with SMARCA4 p.Ser492= (c.1476C>T)?

SMARCA4 p.Ser492= (c.1476C>T) is associated with hereditary neoplastic syndrome, rhabdoid tumor predisposition syndrome 2 (ClinVar).

How common is SMARCA4 p.Ser492= (c.1476C>T) in the general population?

SMARCA4 p.Ser492= (c.1476C>T) is ultra-rare (popmax 0.049%, eas) (gnomAD).

SMARCA4 p.Ser492=

c.1476C>T · rs528531511 · VCV238378

Likely benign Multiple submitters

Classification

Likely benign

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 5 submitters

gnomAD v4.1

Rare

ultra-rare (popmax 0.049%, eas)

Conditions

hereditary neoplastic syndrome

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP -9.6	GERP -4.4
Overall
CADD	0.073	PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.049% East Asian · 22/44,884 alleles

Filtering AF 0.0331% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0279%

Overall 0.00378% 61/1,614,034 alleles · ultra-rare exomes 58/1,461,736 · genomes 3/152,298 · joint denominator

Ancestry group	Frequency	1 in
East Asiangrpmax	0.049%	2,040
European (non-Finnish)	0.00314%	31,890
Remaining individualsnot grpmax-eligible	0.0016%	62,500
African / African-American	0.00133%	75,038

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: SMARCA4
Protein: p.Ser492=
Coding: c.1476C>T
MANE Select: NM_003072
dbSNP: rs528531511
Type: single nucleotide variant
Location: chr19:10994884 (GRCh38)
Gene constraint: LOEUF 0.226 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure: AlphaFold pLDDT 65.38 · 31 PDB
Residue 492: the hsa domain; the 'rna-binding region which is sufficient for binding to lncrna evf2' region

Full SMARCA4 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary neoplastic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: rhabdoid tumor predisposition syndrome 2

Similar variants

SMARCA4 p.Ser492Cys Uncertain significance ★★ ⚠ same residue
SMARCA4 p.Ser492Phe Uncertain significance ★ ⚠ same residue
SMARCA4 p.Ser492fs Pathogenic ★★ same residue
SMARCA4 c.1943+1G>A Likely pathogenic ★★ same condition
SMARCA4 c.2274+1G>T Likely pathogenic ★★ same condition
SMARCA4 c.2438+1G>A Pathogenic/Likely pathogenic ★★ same condition
SMARCA4 c.3216-1G>C Likely pathogenic ★★ same condition
SMARCA4 c.3216-2A>G Likely pathogenic ★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/smarca4-p-ser492 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown